RY
Therapeutic Areas
ALPCO Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MADx ALEX2 Allergy Explorer | Allergen sensitization (IgE detection) | Approved/Commercial |
| MADx ALEX3 Allergy Explorer | Allergen sensitization (IgE detection) | Approved/Commercial |
| MADx FOX Food Xplorer | Food intolerance/tolerance (IgG detection) | Approved/Commercial |
| GeneProof CT/NG/MG Multiplex PCR Kit | Sexually Transmitted Infections (Chlamydia, Gonorrhea, Mycoplasma) | Approved/Commercial |
| GeneProof CMV PCR Kit | Cytomegalovirus infection/viral load | Approved/Commercial |
| GeneProof HPV Screening PCR Kit | Human Papilloma Virus infection | Approved/Commercial |
| GeneProof HHV-8 PCR Kit | Human Herpesvirus 8 infection | Approved/Commercial |
| myCROBE Instrument | Automated sample-to-answer PCR | Approved/Commercial |
Leadership Team at ALPCO Diagnostics
EA
Erik Allen
Chief Executive Officer
FF
Francesco Fragasso
Chief Financial Officer
BB
Bethany Bell
Vice President, Global Business Development
TM
Tarika Mansukhani
Vice President, Global Product Management and Marketing
LC
Luke Christensen
Vice President, Global Sales
JR
Jim Richard
Vice President, Quality and Regulatory
CW
Chris Wisherd
Vice President, Scientific Operations
KD
Kimberly DiBurro
Global Director, Marketing